Pierre‐Yves Dietrich

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Medicine, Oncology, Pharmacology +13

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Marie Marchand, Nicolas van Baren, P. Weynants et al. · International Journal of Cancer · 1999 · 786 citations

Life Sciences, Immunology, Oncology +17

Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma

Anastasia Murat, Eugenia Migliavacca, Thierry Gorlia et al. · Journal of Clinical Oncology · 2008 · 735 citations · Full text

Medicine, Cancer Biology, Oncology +17

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

Philippe Saas, Paul R. Walker, Michael Hahne et al. · Journal of Clinical Investigation · 1997 · 405 citations · Full text

Life Sciences, Immunology, Oncology +17

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

M. Brada, Khê Hoang‐Xuan, R. Rampling et al. · Annals of Oncology · 2001 · 372 citations · Full text

Medicine, Oncology, Pharmacology +15